Delivery Order SPE2DB24D1104-SPE2DB25FYAZ2

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,070.16, is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S. This is a firm fixed-price delivery order contract with a performance period through March 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,274.55, is a Firm Fixed Price Delivery Order for the supply of 4567533906 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.51 firm-fixed-price delivery order is for the supply of 4566802887 LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 Firm Fixed Price delivery order contract is for the supply of 4567113134 LISDEXAMFETAMINE 30 MG CAPSULE 100S, which will be delivered by January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,885.97, is for the delivery of 4567615863 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,180.65 delivery order contract is for the supply of 4567113101 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,213.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of LISDEXAMFETAMINE 60 MG CAPSULE 100S, with a performance period through March 25, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,783.60, is a delivery order contract for the delivery of 4567197460 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of February 7, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $15,076.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566963272 - LISDEXAMFETAMINE 40 MG CAPSULE 100S, a prescription medication, with a period of performance through January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,328.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567038547 - LISDEXAMFETAMINE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYAZ2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,770.19 firm fixed-price delivery order is for the supply of 4568249118 - LISDEXAMFETAMINE 20 MG CAPSULE 100S, with a period of performance through May 15, 2025. The contract is not set aside for any specific business type.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/13/25, 10:54 AM